METLIFE INC (MET) Stock Analyst Ratings
NYSE:MET • US59156R1086
75.34 USD
+0.1 (+0.13%)
At close: Feb 24, 2026
75.34 USD
0 (0%)
After Hours: 2/24/2026, 8:04:00 PM
ChartMill assigns a Buy % Consensus number of 79% to MET. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 95.08. This target is 26.2% above the current price.
- MET was analyzed by 21 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about MET.
- In the previous month the buy percentage consensus was at a similar level.
- MET was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-11 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-02-05 | UBS | Maintains | Buy -> Buy |
| 2026-01-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-08 | UBS | Maintains | Buy -> Buy |
| 2025-12-23 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-16 | Mizuho | Initiate | Outperform |
| 2025-11-11 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-11-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-06 | UBS | Maintains | Buy -> Buy |
| 2025-10-08 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-07 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-19 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-09-16 | Wolfe Research | Initiate | Outperform |
| 2025-08-18 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-11 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-08-11 | Jefferies | Maintains | Buy -> Buy |
| 2025-08-07 | UBS | Maintains | Buy -> Buy |
| 2025-07-14 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-07-10 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-09 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-07-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-05-19 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-11 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-10 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-10 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-04-09 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-04-02 | UBS | Maintains | Buy -> Buy |
METLIFE INC / MET FAQ
What is the price target for MET stock?
21 analysts have analysed MET and the average price target is 95.08 USD. This implies a price increase of 26.2% is expected in the next year compared to the current price of 75.34.
Can you provide the consensus rating for METLIFE INC stock?
The consensus rating for METLIFE INC (MET) is 79.0476 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for METLIFE INC stock?
The number of analysts covering METLIFE INC (MET) is 21.